BNP Paribas Financial Markets
ATOS icon

BNP Paribas Financial Markets’s Atossa Therapeutics ATOS Stock Holding History

BNP Paribas Financial Markets’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168 Sell
87
-11
-11% -$50 ﹤0.01% 5760
2026
Q1 		$515 Sell
98
-2
-2% -$13 ﹤0.01% 5543
2025
Q4 		$883 Buy
100
+1
+1% +$13 ﹤0.01% 5415
2025
Q3 		$1.29K Sell
99
-102
-51% -$1.26K ﹤0.01% 5210
2025
Q2 		$2.5K Sell
201
-360
-64% -$4.3K ﹤0.01% 5034
2025
Q1 		$5.66K Sell
561
-505
-47% -$6.13K ﹤0.01% 4832
2024
Q4 		$15.1K Sell
1,066
-619
-37% -$12.1K ﹤0.01% 4770
2024
Q3 		$38.4K Buy
1,685
+388
+30% +$7.83K ﹤0.01% 3667
2024
Q2 		$23.2K Buy
1,297
+993
+327% +$22K ﹤0.01% 3621
2024
Q1 		$8.2K Hold
304
– – ﹤0.01% 3706
2023
Q4 		$4.01K Hold
304
– – ﹤0.01% 3768
2023
Q3 		$3.35K Hold
304
– – ﹤0.01% 3685
2023
Q2 		$5.74K Hold
304
– – ﹤0.01% 3663
2023
Q1 		$3.3K Sell
304
-337
-53% -$3.76K ﹤0.01% 3610
2022
Q4 		$5.08K Hold
641
– – ﹤0.01% 3665
2022
Q3 		$8.02K Sell
641
-574
-47% -$8.34K ﹤0.01% 4204
2022
Q2 		$19.9K Sell
1,215
-989
-45% -$15.6K ﹤0.01% 3696
2022
Q1 		$41.3K Sell
2,204
-1,204
-35% -$24.5K ﹤0.01% 3591
2021
Q4 		$81.8K Buy
3,408
+1,599
+88% +$58.5K ﹤0.01% 3648
2021
Q3 		$88.5K Buy
1,809
+1,110
+159% +$64.6K ﹤0.01% 3321
2021
Q2 		$66.3K Buy
+699
New +$37K ﹤0.01% 3163

Other funds holding ATOS

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BNP Paribas Financial Markets's ATOS Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Atossa Therapeutics (ATOS) stake by 11% in Q2 2026, selling an estimated $50 and leaving 87 shares worth $168. The position accounts for ﹤0.01% of the portfolio, ranked #5760.

BNP Paribas Financial Markets first reported a position in ATOS in Q2 2021 and has held it in 21 quarters since. The position peaked at $88.5K in Q3 2021. 31 funds tracked by Wall St. Rank hold ATOS as of Q2 2026.

  • BNP Paribas Financial Markets held 87 shares of Atossa Therapeutics worth $168 as of Q2 2026.
  • BNP Paribas Financial Markets sold 11 Atossa Therapeutics shares in Q2 2026, an estimated $50.
  • Atossa Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5760 holding.
  • BNP Paribas Financial Markets first reported a position in Atossa Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • BNP Paribas Financial Markets's Atossa Therapeutics position peaked at $88.5K in Q3 2021.
  • 31 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.